As of 2026-06-10, the Relative Valuation of Mithra Pharmaceuticals SA (MITRA.BR) is (35.82) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.22 EUR, the upside of Mithra Pharmaceuticals SA based on Relative Valuation is -16681.8%.
The range of the Relative Valuation is (34.61) - (45.86) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.4x - 13.7x | 10.3x |
| Forward P/E multiples | 10.3x - 14.4x | 11.1x |
| Fair Price | (34.61) - (45.86) | (35.82) |
| Upside | -16123.9% - -21330.9% | -16681.8% |
| Date | P/E |